痰热清注射液联合常规抗感染治疗对脑梗死患者肺部感染的治疗效果观察

发布时间：2018-02-10 03:08

本文关键词： 痰热清常规抗菌药物脑梗死肺感染　出处：《中华医院感染学杂志》2017年22期 　论文类型：期刊论文

【摘要】：目的比较联合痰热清注射液和常规抗感染治疗脑梗死患者肺部感染的效果。方法选取2014年1月-2016年1月在医院接受治疗的脑梗死并发肺部感染患者60例,随机分为试验组与对照组,各30例,两组患者均进行脑梗死并发肺部感染的常规治疗,试验组患者在常规治疗基础上加用痰热清注射液治疗,10天后对比两组患者的疗效、咳嗽停止时间、体温恢复时间、肺部Up音消失时间、患者动脉血氧分压(PaO_2)、血清白细胞计数、CRP和24小时内痰量情况。结果治疗后试验组患者总有效率为93.3%,高于对照组73.3%,差异有统计学意义(P0.05);试验组患者咳嗽停止、体温恢复和肺部Up音消失时间均低于对照组,两组差异有统计学意义(P0.05);试验组患者痰量、血清CRP、白细胞计数均低于对照组,PaO_2高于对照组,两组差异均有统计学意义(P0.05)。结论痰热清对脑梗死并发肺部感染患者疗效显著,值得在临床推广使用。
[Abstract]:Objective to compare the effect of combined Tanreqing injection and routine anti-infective therapy on pulmonary infection in patients with cerebral infarction. Methods 60 patients with pulmonary infection were treated in hospital from January 2014 to January 2016. The patients in the experimental group were divided into two groups randomly, 30 cases in each group. The patients in both groups were treated with routine therapy of pulmonary infection after cerebral infarction. The patients in the test group were treated with Tanreqing injection on the basis of routine treatment for 10 days. Cough stop time, body temperature recovery time, lung up sound disappear time, Results after treatment, the total effective rate of the patients in the trial group was 93.3, which was higher than that in the control group (73.3%), the difference was statistically significant (P0.05), and the cough stopped in the test group. The recovery of body temperature and the disappearance time of pulmonary up sound were lower than those of the control group (P 0.05), and the sputum volume, serum CRP, white blood cell count in the test group were lower than those in the control group, and that in the control group was higher than that in the control group. Conclusion Tanreqing is effective in the treatment of cerebral infarction complicated with pulmonary infection, and it is worth popularizing in clinic.
【作者单位】：中国核工业北京四0一医院急诊科;中国核工业北京四0一医院神经内科;
【基金】：首都卫生发展科研专项基金资助项目(首发2011-2002-04)
【分类号】：R563.1;R743.3

【相似文献】